rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-11
|
pubmed:abstractText |
FK506 has been extensively used in preventing immune rejection for human organ transplantation. This study aimed to evaluate the effects of a biodegradable FK506 drug delivery system (DDS) implanted into anterior chamber for the prolongation of corneal allograft survival in high-risk keratoplasty.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0271-3683
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
969-76
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16282131-Absorbable Implants,
pubmed-meshheading:16282131-Animals,
pubmed-meshheading:16282131-Cornea,
pubmed-meshheading:16282131-Corneal Transplantation,
pubmed-meshheading:16282131-Drug Delivery Systems,
pubmed-meshheading:16282131-Graft Rejection,
pubmed-meshheading:16282131-Graft Survival,
pubmed-meshheading:16282131-Hexanoic Acids,
pubmed-meshheading:16282131-Lactones,
pubmed-meshheading:16282131-Osmolar Concentration,
pubmed-meshheading:16282131-Polyesters,
pubmed-meshheading:16282131-Polymers,
pubmed-meshheading:16282131-Rabbits,
pubmed-meshheading:16282131-Tacrolimus,
pubmed-meshheading:16282131-Time Factors,
pubmed-meshheading:16282131-Transplantation, Homologous
|
pubmed:year |
2005
|
pubmed:articleTitle |
FK506 in a biodegradable glycolide-co-clatide-co-caprolactone polymer for prolongation of corneal allograft survival.
|
pubmed:affiliation |
Shandong Eye Institute, Qingdao, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|